Patrick Connor at AstraZeneca, discusses The Lung Ambition Alliance and their goal to double the 5-year survival rate and to one day eliminate lung cancer.
INTERVIEWS
Attacking brain cancer from a completely new angle with an industry-first approach
Dr. Nader Sanai discusses attacking brain cancer from a completely new angle with an industry-first approach based on three key pillars.
Cutaneous squamous cell carcinoma, a poorly-known type of skin cancer
Dr. Ostad discusses cutaneous squamous cell carcinoma (CSCC) & the survey that showed that many people are not aware of this type of skin cancer.
How to control drug-resistant epilepsy
Greg Grunberg, an epilepsy advocate, discusses his son who suffers from drug-resistant epilepsy & the treatments he uses to control his epilepsy now.
HIV treatment & latest research
Dr. Kimberly Smith, Head of Global Research and Medical Strategy at ViiV Healthcare, discusses the latest advances and research on the challenges facing patients with HIV.
Can the New England Journal of Medicine be trusted?
Theodore Dalrymple discusses his new book where he says that many of the papers published in the NEJM are obviously flawed.
How social norms affect mental health issues in men
Dr. Brad Berger discusses depression and mental health issues in men that are often not talked about due to social norms.
Study for treatment of patients with severe rosacea
Dr. James Q. Del Rosso discusses new data from the Phase 3b/4 ANSWER study and what this could mean for patients with severe rosacea.
Sleep hygiene – how to sleep better?
Drew Ackerman discusses sleep hygiene, available alternatives, & his partnering with the evidence-based natural sleep therapy, Flordis ReDormin Forte.
The four major advancements in the nation’s stroke prevention paradigm
Dr. Joshua Yamamoto discusses the four major advancements in the nation’s stroke prevention paradigm & his new book, “You Can Prevent A Stroke”.